Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyed H Moosavi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Letters|November 4, 2019
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancerIna A Eilertsen, Seyed H Moosavi, Jonas M Strømme, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2022
Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancerChristian H Bergsland, Marine Jeanmougin, Seyed H Moosavi, et al.
Journal of Translational Medicine|September 9, 2021
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastasesKushtrim Kryeziu, Seyed H Moosavi, Christian H Bergsland, et al.
NPJ Genomic Medicine|July 15, 2021
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancerPeter W Eide, Seyed H Moosavi, Ina A Eilertsen, et al.
The British Journal of Surgery|April 16, 2025
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancerSeyed H Moosavi, Kushtrim Kryeziu, Ina A Eilertsen, et al.
Oncogenesis|January 27, 2026
Common gene mutations in 103 authenticated colorectal cancer cell linesChristian Kranjec, Ina A Eilertsen, Luís Nunes, et al.
Nature Communications|May 21, 2024
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancerJonas Langerud, Ina A Eilertsen, Seyed H Moosavi, et al.
Genome Medicine|September 2, 2021
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneitySeyed H Moosavi, Peter W Eide, Ina A Eilertsen, et al.
Cell Reports. Medicine|May 28, 2026
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivityKushtrim Kryeziu, Solveig K Klokkerud, Max Z Totland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic HeterogeneityJarle Bruun, Kushtrim Kryeziu, Peter W Eide, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Letters|November 4, 2019
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancerIna A Eilertsen, Seyed H Moosavi, Jonas M Strømme, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2022
Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancerChristian H Bergsland, Marine Jeanmougin, Seyed H Moosavi, et al.
Journal of Translational Medicine|September 9, 2021
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastasesKushtrim Kryeziu, Seyed H Moosavi, Christian H Bergsland, et al.
NPJ Genomic Medicine|July 15, 2021
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancerPeter W Eide, Seyed H Moosavi, Ina A Eilertsen, et al.
The British Journal of Surgery|April 16, 2025
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancerSeyed H Moosavi, Kushtrim Kryeziu, Ina A Eilertsen, et al.
Oncogenesis|January 27, 2026
Common gene mutations in 103 authenticated colorectal cancer cell linesChristian Kranjec, Ina A Eilertsen, Luís Nunes, et al.
Nature Communications|May 21, 2024
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancerJonas Langerud, Ina A Eilertsen, Seyed H Moosavi, et al.
Genome Medicine|September 2, 2021
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneitySeyed H Moosavi, Peter W Eide, Ina A Eilertsen, et al.
Cell Reports. Medicine|May 28, 2026
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivityKushtrim Kryeziu, Solveig K Klokkerud, Max Z Totland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic HeterogeneityJarle Bruun, Kushtrim Kryeziu, Peter W Eide, et al.
Pageof 1